Usefulness of monocyte distribution width (MDW) as a sepsis biomarker

• Autores: Sara Laínez Martínez, Juan González del Castillo
• Localización: Revista Española de Quimioterapia, ISSN-e 0214-3429, Vol. 35, Nº Extra 1, 2022, págs. 2-5
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)
• Resumen

  • Sepsis is one of the main causes of mortality in the emergency department (ED), due to the fact that signs and symptoms are common to other acute diseases, and this can result in delayed detection. This diagnostic complexity has a huge impact on an entity in which early recognition determined treatment, as wells as enhance the patient’s prognosis.

    Therefore, it is crucial to improve early identification. Different analytical tools arise from this approach, such as biomarkers:

    procalcitonin, C-reactive protein or MR-proadrenomedullin. In this review we will focus on a newer biomarker, the monocyte distribution width. The main objectives are to evaluate the usefulness of monocyte distribution width (MDW) in sepsis identification in ED, its limitations, and to compare it with other biomarkers.